EVAX
Price
$3.12
Change
+$0.04 (+1.30%)
Updated
Sep 4 closing price
Capitalization
28.24M
75 days until earnings call
Intraday BUY SELL Signals
IKT
Price
$2.50
Change
-$0.02 (-0.79%)
Updated
Sep 4 closing price
Capitalization
348.84M
72 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EVAX vs IKT

EVAX vs IKT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EVAX vs. IKT commentary
Sep 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a StrongBuy and IKT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2026
Stock price -- (EVAX: $3.12 vs. IKT: $2.50)
Brand notoriety: EVAX and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 34% vs. IKT: 38%
Market capitalization -- EVAX: $28.24M vs. IKT: $348.84M
EVAX [@Biotechnology] is valued at $28.24M. IKT’s [@Biotechnology] market capitalization is $348.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 1 FA rating(s) are green whileIKT’s FA Score has 0 green FA rating(s).

  • EVAX’s FA Score: 1 green, 4 red.
  • IKT’s FA Score: 0 green, 5 red.
According to our system of comparison, IKT is a better buy in the long-term than EVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 5 TA indicator(s) are bullish while IKT’s TA Score has 4 bullish TA indicator(s).

  • EVAX’s TA Score: 5 bullish, 5 bearish.
  • IKT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, IKT is a better buy in the short-term than EVAX.

Price Growth

EVAX (@Biotechnology) experienced а +3.65% price change this week, while IKT (@Biotechnology) price change was +3.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.22%. For the same industry, the average monthly price growth was +5.23%, and the average quarterly price growth was +2396.59%.

Reported Earning Dates

EVAX is expected to report earnings on Nov 19, 2026.

IKT is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IKT($349M) has a higher market cap than EVAX($28.2M). IKT YTD gains are higher at: 21.951 vs. EVAX (-34.591). EVAX has higher annual earnings (EBITDA): -9.88M vs. IKT (-55.75M). IKT has more cash in the bank: 170M vs. EVAX (18.4M). IKT has less debt than EVAX: IKT (0) vs EVAX (11.3M). EVAX has higher revenues than IKT: EVAX (7.53M) vs IKT (0).
EVAXIKTEVAX / IKT
Capitalization28.2M349M8%
EBITDA-9.88M-55.75M18%
Gain YTD-34.59121.951-158%
P/E RatioN/A3.47-
Revenue7.53M0-
Total Cash18.4M170M11%
Total Debt11.3M0-
TECHNICAL ANALYSIS
Technical Analysis
EVAXIKT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
EVAX
Daily Signal:
Gain/Loss:
IKT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BAFAX46.47N/A
N/A
Brown Advisory Flexible Equity Adv
ASRIX8.86N/A
N/A
Invesco Global Real Estate Income R5
ASVIX10.76N/A
N/A
American Century Small Cap Value Inv
FLCPX31.06N/A
N/A
Fidelity SAI US Large Cap Index
CIMDX18.32N/A
N/A
Clarkston Founders Institutional